Replies to post #7716 on Theriva Biologics Inc (TOVX)

[Citrati]

Hard to say.
When you have an interim CEO weakness is multiplied because no clear direction has been indicated.
With no positive news it is the nature of stocks that it begets more weakness.
As long a the present unknowns remain unknown weakness is likely to continue.
Just the way it is.
There will likely be a trade again. Just don't know when yet.